Biden Administration Unveils First Drugs for Medicare Price Negotiations
The Biden administration on Tuesday unveiled a long-awaited list of the first 10 medicines that will be subject to price negotiations with Medicare, kicking off a landmark program that is expected to reduce the government’s drug spending but is being fought by the pharmaceutical industry in court. The medications — which treat diabetes, cancer and…